Mkt Cap$2.24T-0.24%
24h Vol$62.47B
BTC Dom56.1%
ETH Dom9.6%
F&G22Extreme Fear
BTC$62,769.00-0.20% ETH$1,795.23+0.98% USDT$0.9988-0.02% BNB$570.12+0.34% USDC$0.9999+0.01% XRP$1.07-0.75% SOL$75.21-1.19% TRX$0.3248-0.76% FIGR_HELOC$1.03+1.91% HYPE$63.84-1.72% DOGE$0.0721-0.02% USDS$0.9999+0.02% RAIN$0.0142-1.58% LEO$9.55+0.30% ZEC$507.33-1.11% WBT$55.10+0.04% BTC$62,769.00-0.20% ETH$1,795.23+0.98% USDT$0.9988-0.02% BNB$570.12+0.34% USDC$0.9999+0.01% XRP$1.07-0.75% SOL$75.21-1.19% TRX$0.3248-0.76% FIGR_HELOC$1.03+1.91% HYPE$63.84-1.72% DOGE$0.0721-0.02% USDS$0.9999+0.02% RAIN$0.0142-1.58% LEO$9.55+0.30% ZEC$507.33-1.11% WBT$55.10+0.04%
News

Merck

Total Stories
4
Section
Merck
Why Is Moderna (MRNA) Stock Up Today: Merck Partnered Vaccine Cuts Recurrence Risk
Market Analysis

Why Is Moderna (MRNA) Stock Up Today: Merck Partnered Vaccine Cuts Recurrence Risk

Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, cutting recurrence or death risk by 49%.

Tim FriesJan 21, 20263 min read